DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Frequently asked questions
What sector does DiaSorin S.p.A (DSRLF) operate in?
DiaSorin S.p.A belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is DiaSorin S.p.A (DSRLF) current stock price?
As of the latest data, DiaSorin S.p.A stock price is $88.21, with a previous close of $88.21.
What is DiaSorin S.p.A (DSRLF) current market capitalization?
DiaSorin S.p.A market cap is approximately 4.35 billion.
What is DiaSorin S.p.A (DSRLF) Earnings Per Share (EPS)?
The trailing EPS is $3.17.
What is DiaSorin S.p.A (DSRLF) Price-to-Earnings (P/E) ratio?
DiaSorin S.p.A current P/E ratio is 27.83.
What is DiaSorin S.p.A (DSRLF) EBITDA?
DiaSorin S.p.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 198.12 million.
Does DiaSorin S.p.A (DSRLF) pay dividends?
Yes. DiaSorin S.p.A pays annual dividends with an annualized yield of 1.71% and an estimated annual payout of $1.51 per share.
When is the next ex-dividend date for DiaSorin S.p.A (DSRLF)?
The next ex-dividend date is scheduled for May 19, 2027.
What is DiaSorin S.p.A (DSRLF) beta (volatility) score?
DiaSorin S.p.A has a beta of 0.674, indicating lower volatility than the overall market.
